ICU Medical Inc.
ICUI | NASDAQ
$163.78
-$4.87 (-2.89%)
At close: Oct 30, 2026, 4:00 PM ET
$163.78
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:18 PM ET
Market Data
Market Cap $4.1B
Enterprise Value $5.07B
Beta 0.76
Average Volume 274.37K
Shares Outstanding (Diluted) 25.04M
Shares Change YoY 1.36%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US44930G1076
Price Performance
Price Change 1M 2.0%
Price Change 3M -2.8%
Price Change 6M 37.8%
Price Change YTD 14.8%
Price Change 1Y 36.4%
Price Change 3Y 67.0%
Price Change 5Y -30.1%
1M CAGR (ann.) 7.3%
1Y CAGR (ann.) 39.2%
5Y CAGR (ann.) -6.2%
All-Time CAGR 1.8%
Valuation
PE Ratio 138.80
Forward PE 16.76
PEG Ratio 0.01
Forward PEG 8.85
PS Ratio 1.90
Forward PS 1.80
PB Ratio 1.90
P/FCF Ratio 26.80
P/Adj. FCF Ratio 36.66
P/OCF Ratio 17.33
EV/Sales 2.35
EV/EBIT 118.36
EV/EBITDA 17.03
EV/FCF 33.17
Earnings Yield 0.7%
FCF Yield 3.7%
Adj. FCF Yield 2.7%
Financial Health
Net Debt $932.9M
Total Debt $1.27B
Cash & Short-Term Investments $298.3M
Total Assets $3.97B
Current Ratio 2.43
Quick Ratio 1.21
Debt / Equity Ratio 0.59
Debt / EBITDA 4.27
Debt / FCF 8.32
OCF / Debt 0.19
Interest Coverage 1.31
Altman Z-Score 2.41
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 37.6%
Operating Profit Margin 5.0%
EBITDA Margin 11.5%
Net Profit Margin 1.4%
FCF Margin 7.1%
Adj. FCF Margin 5.2%
SBC / Revenue 1.9%
SBC Impact (per share) -26.9%
Returns
Return on Assets 0.8%
Return on Equity 1.4%
Return on Invested Capital -21.7%
Return on Capital Employed 3.1%
Return on Tangible Assets 1.6%
Historical Growth (CAGR)
Revenue CAGR 3Y -2.0%
Revenue CAGR 5Y 11.1%
Revenue CAGR 10Y 19.5%
EPS CAGR 3Y 188.7%
EPS CAGR 5Y -24.4%
EPS CAGR 10Y -10.0%
FCF CAGR 3Y -2.6%
FCF CAGR 5Y -2.6%
FCF CAGR 10Y 11.2%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 4
EPS Growth Next 3Y 106.1%
Revenue Growth Next 3Y 2.3%
Earnings Date Nov 5, 2026
EPS Estimate (next Q) $2.14
EPS Growth Est (next Q) 5.4%
Revenue Est (next Q) $552.07M
Revenue Growth Est (next Q) 2.8%
Fair Value Estimates
Graham Number $47.80
Graham Upside -70.8%
Lynch Fair Value $5.90
Lynch Upside -96.4%
Price Target $192.25
Price Target Upside 17.4%
Cash Flow
Operating Cash Flow $236.37M
Free Cash Flow $152.83M
Adj. Free Cash Flow $111.71M
FCF Per Share $6.11
OCF Per Share $9.45
OCF/S Ratio 10.9%
Income Statement
Revenue $2.16B
Gross Profit $811.16M
Operating Income $108.76M
EBITDA $297.64M
Net Income $30.09M
EPS (Diluted) $1.18
Revenue / Employee $166.1K
Profit / Employee $2.31K
Employees 13,000
Add to Watchlist
Select watchlists to add or remove ICUI